William Janzen

William Janzen

Director Assay Development and Compound Profiling, Center for Integrated Chemical Biology and Drug Discovery, UNC Eshelman School of Pharmacy

William LaMarr

William LaMarr

Senior R&D Manager, Head of Discovery Services


The Promise of Epigenetics in Early Stage Drug Discovery

Duration: 1 hours

View recording

William Janzen, a highly respected academic in the field of epigenetics and a founder of SBS, will be presenting a summary of epigenetics and why it is important to drug discovery, as well as recent advances in his research and that from other groups. In addition, Bill LaMarr will present the RapidFire high-throughput mass spectrometry system, highlighting a number of case studies including histone methylation, acetylation and deacetylation.


Share this webinar

More services